Home > Riviste > Minerva Obstetrics and Gynecology > Fascicoli precedenti > Minerva Ginecologica 2020 August;72(4) > Minerva Ginecologica 2020 August;72(4):219-28



Opzioni di pubblicazione
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca


Publication history
Per citare questo articolo


ORIGINAL ARTICLE   Free accessfree

Minerva Ginecologica 2020 August;72(4):219-28

DOI: 10.23736/S0026-4784.20.04675-4


lingua: Inglese

An innovative device in the management of female urodynamic stress incontinence: a perception survey

Marco SOLIGO 1 , Marco TORELLA 2, Matteo BALZARRO 3, Maria G. MATARAZZO 4, Andrea BRAGA 5, Maurizio SERATI 6 on behalf of the Italian Urodynamic Society (SIUD)

1 Unit of Urogynecology, Department of Woman, Mother, and Neonate, Buzzi Children’s Hospital, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy; 2 Department of Gynecology, Obstetric and Reproductive Science, Second University of Naples, Naples, Italy; 3 Department of Urology, University Hospital of Verona, Verona, Italy; 4 Gynecological Clinic, University Polyclinic of Catania, Catania, Italy; 5 Department of Obstetrics and Gynecology, EOC-Beata Vergine Hospital, Mendrisio, Switzerland; 6 Department of Obstetrics and Gynecology, University of Insubria, Varese, Italy

BACKGROUND: Urinary incontinence significantly affects daily life of suffering women. Minimally invasive solutions to cope with urine leakage would be of great interest.
METHODS: A survey to investigate efficacy and compliance of an innovative intravaginal device (Diveen®) to reduce the risk of urine leakage was performed in 5 Urogynecological Centers across Italy. Women with urodynamic diagnosis of stress incontinence, included mixed conditions, underwent the survey.
RESULTS: The device was effective (60%) independently from severity of Incontinence or the presence of concomitant detrusor overactivity (mixed forms) with a positive impact on quality of life in more than half of the women. Also compliance with the device was satisfactory (up to 73%). Clinically symptomatic prolapse and age >65 years are the only limiting factors in terms of efficacy and compliance, while the menopausal status would not seem to affect these aspects.
CONCLUSIONS: Despite global satisfactory outcomes, 46% of the surveyed women declare their propensity to use the device. This data deserves further investigation.

KEY WORDS: Surveys and questionnaire; Urinary incontinence; Urodynamics; Quality of Life; Compliance

inizio pagina